Tonix Pharmaceuticals Holding Corp. 8-K

What Happened

• Tonix Pharmaceuticals Holding Corp. (TNXP) filed an 8-K (Items 7.01 and 8.01) announcing that Nasdaq approved the transfer of the company’s common stock from The Nasdaq Capital Market to The Nasdaq Global Select Market. The transfer became effective at the open of market on March 3, 2026.

Key Details

• Nasdaq approval to transfer listing received and effective March 3, 2026 (open of market).
• Move is from The Nasdaq Capital Market to The Nasdaq Global Select Market.
• The company filed a related press release dated March 3, 2026 (Exhibit 99.01) with the 8-K.

Why It Matters

• The Nasdaq Global Select Market is Nasdaq’s highest listing tier and has more stringent listing standards than the Capital Market; the transfer means Tonix’s common stock will be listed on that higher tier as of March 3, 2026.
• For investors, the filing is an operational/market-structure update rather than a financial report—no earnings, management changes, or other material financial disclosures were reported in this 8-K.